CMPX vs TFC · $367.4M cap vs rev $24.54B
Compass Therapeutics Inc. (CMPX) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
TFC (TFC) common stock.
CMPX does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
CMPX currently screens at market cap $367.4M. TFC currently screens at market cap $0.
Not investment advice. Open the CMPX and TFC stock pages for the full models.
Not investment advice.